Monsanto Company (MON) traded higher in the last at $108.46, gaining 0.15 points or 0.14%. From the data available, it can be said that the stock did not make an impact in the money flow department with the net figure coming to be $(-14.19) million. The composite uptick value of $20.69 million was eclipsed by the accrued downtick value of $34.88 million, thereby ensuring the up/down ratio of 0.59. For the week, the shares have posted returns of -0.86%.A block trade registered during the day has revealed $0 million in upticks and $11.58 million in downticks. The up/down ratio in this case turned out to be 0. The net money flow for the block trade was $(-11.58) million.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Monsanto Company has dropped 2.15% in the last five trading days, however, the shares have posted positive gains of 3.62% in the last 4 weeks. Monsanto Company is up 8.19% in the last 3-month period. Year-to-Date the stock performance stands at 3.62%. Monsanto Company (NYSE:MON) rose 0.14% or 0.15 points on Wednesday and made its way into the gainers of the day. After trading began at $108.28 the stock was seen hitting $109.33 as a peak level and $108.2 as the lowest level. The stock ended up at $108.46. The daily volume was measured at 1,190,221 shares. The 52-week high of the share price is $114.26 and the 52-week low is $83.73. The company has a market cap of $47,566 million.
Company has reported several Insider transactions to the SEC, on Jan 27, 2017, Michael K Stern (VP, and CEO, Climate) sold 5,670 shares at 110.00 per share price.On Jan 12, 2017, Steven Mizell (EVP, Chief HR Officer) sold 2,525 shares at 108.56 per share price.On Nov 17, 2016, Kerry J Preete (EVP, Chief Strategy Officer) sold 2,745 shares at 100.96 per share price.
Monsanto Company Last issued its quarterly earnings results on Jan 5, 2017. The company reported $0.21 EPS for the quarter, beating the analyst consensus estimate by $ 0.22. Analyst had a consensus of $-0.01. The company had revenue of $2650.00 million for the quarter, compared to analysts expectations of $2295.33 million. The companys revenue was up 19.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.11 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Monsanto Company was Upgraded by CLSA to Outperform on Jan 6, 2017.
Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.